September 18-20, 2017
Ocean Place Resort, Long Branch, NJ

> 2017 Exhibitors

> 2016 Exhibitors

> 2014 Exhibitors

Download Exhibitor Manual

Download Exhibitor Electric Form

ChemOutsourcing Banner To Alert Contacts You’re Attending

2017 Exhibitor List

read: buyers and suppliers together

Exhibitor List As Of September 22, 2017

Look for exhibitors according to their first letter.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Show All

 

J-Star Research
Jiuzhou Pharmaceutical
Johnson Matthey
Jubilant Biosys Ltd

J-Star Research

Jiuzhou Pharmaceutical

Johnson Matthey

Johnson Matthey Fine Chemicals combines our proven specialist expertise and 200-year heritage to deliver a collaborative service offering focused on strengthening your products to ensure they get to market more efficiently. Built around core offerings of Custom Pharma Solutions, Controlled Substances, Catalysts, API & Life Cycle Management, our industry leading technologies and expertise, coupled with our global manufacturing footprint, enable us to deliver expert solutions for all your complex chemistry needs.

Our diverse technologies and capabilities include an unmatched portfolio of catalyst technologies; chiral synthesis; highly potent APIs and controlled substances; drug-conjugates and linker technologies; solid form sciences; manufacturing-scale chromatography; large scale cryogenics and process analytical technologies. Our custom development and manufacturing services are provided through a global network of eleven facilities in Europe, North America and Asia.

Jubilant Biosys Ltd

Jubilant Biosys Limited (JBL) & Jubilant Chemsys Limited (JCL), collectively referred to as Jubilant, are sister concerns of Jubilant Life Sciences (a $900MM Sales Corporation) providing innovative drug discovery services to the global life sciences, agrochemicals and specialty chemicals industry through its multi-location research centers (India and USA). Partnering with the Global Top-10 Pharma, Jubilant's team of 600+ scientists have an track record of working on 60+ integrated programs out of which 12 successfully delivered at Lead Optimization/ IND stage, Jubilant's services in discovery research include:

  • Target Identification/ Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain, Inflammation, Fibrosis and Respiratory diseases.
  • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK, in-vitro and in-vivo biology and IND enabling GLP toxicology.